ES2650170T3 - Agente para la medición de endotoxinas - Google Patents
Agente para la medición de endotoxinas Download PDFInfo
- Publication number
- ES2650170T3 ES2650170T3 ES12710808.2T ES12710808T ES2650170T3 ES 2650170 T3 ES2650170 T3 ES 2650170T3 ES 12710808 T ES12710808 T ES 12710808T ES 2650170 T3 ES2650170 T3 ES 2650170T3
- Authority
- ES
- Spain
- Prior art keywords
- factor
- seq
- amino acid
- acid sequence
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002158 endotoxin Substances 0.000 title claims abstract description 142
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 69
- 238000005259 measurement Methods 0.000 title description 28
- 210000004027 cell Anatomy 0.000 claims abstract description 92
- 238000000034 method Methods 0.000 claims abstract description 92
- 108090000790 Enzymes Proteins 0.000 claims abstract description 86
- 102000004190 Enzymes Human genes 0.000 claims abstract description 83
- 239000003805 procoagulant Substances 0.000 claims abstract description 76
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 75
- 108090000056 Complement factor B Proteins 0.000 claims abstract description 74
- 102000003712 Complement factor B Human genes 0.000 claims abstract description 71
- 108020004414 DNA Proteins 0.000 claims abstract description 64
- 239000003550 marker Substances 0.000 claims abstract description 50
- 241000238631 Hexapoda Species 0.000 claims abstract description 47
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 41
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 38
- 241000700605 Viruses Species 0.000 claims abstract description 34
- 241000239224 Tachypleus tridentatus Species 0.000 claims abstract description 24
- 238000001914 filtration Methods 0.000 claims abstract description 21
- 239000012510 hollow fiber Substances 0.000 claims abstract description 16
- 239000012528 membrane Substances 0.000 claims abstract description 15
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims abstract description 14
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims abstract description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 13
- 210000004899 c-terminal region Anatomy 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000011148 porous material Substances 0.000 claims abstract description 6
- 108020005202 Viral DNA Proteins 0.000 claims abstract description 3
- 210000000349 chromosome Anatomy 0.000 claims description 5
- 230000008569 process Effects 0.000 abstract description 8
- 238000006243 chemical reaction Methods 0.000 description 52
- 239000000243 solution Substances 0.000 description 45
- 239000000758 substrate Substances 0.000 description 42
- 238000001514 detection method Methods 0.000 description 36
- 238000006467 substitution reaction Methods 0.000 description 33
- 238000010523 cascade reaction Methods 0.000 description 28
- 239000000523 sample Substances 0.000 description 28
- 230000003612 virological effect Effects 0.000 description 27
- 230000000694 effects Effects 0.000 description 23
- 238000012360 testing method Methods 0.000 description 23
- 230000014509 gene expression Effects 0.000 description 22
- 230000010473 stable expression Effects 0.000 description 22
- 230000015271 coagulation Effects 0.000 description 14
- 238000005345 coagulation Methods 0.000 description 14
- 239000006166 lysate Substances 0.000 description 14
- 238000002156 mixing Methods 0.000 description 13
- 239000000975 dye Substances 0.000 description 12
- 241001529572 Chaceon affinis Species 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 241000701447 unidentified baculovirus Species 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 10
- 108020004705 Codon Proteins 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 238000007792 addition Methods 0.000 description 7
- 239000000701 coagulant Substances 0.000 description 7
- 108010045487 coagulogen Proteins 0.000 description 7
- 239000012228 culture supernatant Substances 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000004913 activation Effects 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 239000012460 protein solution Substances 0.000 description 6
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 5
- 101150111062 C gene Proteins 0.000 description 5
- 241000239205 Merostomata Species 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000010633 broth Nutrition 0.000 description 4
- 108010071063 butyloxycarbonyl-leucyl-glycyl-arginine-4-nitroanilide Proteins 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000239219 Carcinoscorpius rotundicauda Species 0.000 description 3
- 241000239218 Limulus Species 0.000 description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- ZEKAXIFHLIITGV-UHFFFAOYSA-N 7-methoxycoumarin-4-acetic acid Chemical compound OC(=O)CC1=CC(=O)OC2=CC(OC)=CC=C21 ZEKAXIFHLIITGV-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- BABSVXFGKFLIGW-UWVGGRQHSA-N Leu-Gly-Arg Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N BABSVXFGKFLIGW-UWVGGRQHSA-N 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- 102000002262 Thromboplastin Human genes 0.000 description 2
- 108010000499 Thromboplastin Proteins 0.000 description 2
- YTNGABPUXFEOGU-SRVKXCTJSA-N Val-Pro-Arg Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTNGABPUXFEOGU-SRVKXCTJSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- LOHQECMUTAPWAC-UHFFFAOYSA-N coagulin Natural products C1C(C)=C(CO)C(=O)OC1C1(C)C(C2(C)CCC3C4(C(=O)CC=CC4=CCC43)C)(O)CCC24O1 LOHQECMUTAPWAC-UHFFFAOYSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000006179 pH buffering agent Substances 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LXQOQPGNCGEELI-UHFFFAOYSA-N 2,4-dinitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O LXQOQPGNCGEELI-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241001203868 Autographa californica Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 241000239220 Limulus polyphemus Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101710117971 Peptide Y Proteins 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000239221 Tachypleus gigas Species 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 108010049163 horseshoe crab coagulation factor B Proteins 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/579—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43508—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from crustaceans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96402—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals
- G01N2333/96405—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general
- G01N2333/96408—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from non-mammals in general with EC number
- G01N2333/96411—Serine endopeptidases (3.4.21)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/50—Lipopolysaccharides; LPS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161447556P | 2011-02-28 | 2011-02-28 | |
| US201161447556P | 2011-02-28 | ||
| PCT/JP2012/055728 WO2012118226A1 (en) | 2011-02-28 | 2012-02-28 | An agent for measuring endotoxin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2650170T3 true ES2650170T3 (es) | 2018-01-17 |
Family
ID=45888460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17190094T Active ES2763089T3 (es) | 2011-02-28 | 2012-02-28 | Agente para la medición de endotoxinas |
| ES12710808.2T Active ES2650170T3 (es) | 2011-02-28 | 2012-02-28 | Agente para la medición de endotoxinas |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17190094T Active ES2763089T3 (es) | 2011-02-28 | 2012-02-28 | Agente para la medición de endotoxinas |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US20140024062A1 (OSRAM) |
| EP (3) | EP2681564B1 (OSRAM) |
| JP (5) | JP2014510898A (OSRAM) |
| CN (2) | CN103562724B (OSRAM) |
| ES (2) | ES2763089T3 (OSRAM) |
| SG (3) | SG10202110031YA (OSRAM) |
| WO (1) | WO2012118226A1 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2740791A1 (en) * | 2012-12-05 | 2014-06-11 | MicroCoat Biotechnologie GmbH | Method for recombinant production of horseshoe crab Factor C protein in protozoa |
| CN108646019B (zh) | 2012-12-10 | 2021-06-25 | 生化学工业株式会社 | 新重组因子c、其制造方法、及内毒素的测定法 |
| ES2816550T3 (es) | 2012-12-28 | 2021-04-05 | Seikagaku Kogyo Co Ltd | Método de pre-tratamiento para antitrombina III que se va a someter a una prueba de Limulus |
| JP6562765B2 (ja) * | 2015-08-13 | 2019-08-21 | 大日本印刷株式会社 | 電気化学式エンドトキシン濃度検出用容器、電極チップおよびエンドトキシンの検出方法 |
| JP6557090B2 (ja) * | 2015-08-13 | 2019-08-07 | 大日本印刷株式会社 | 電極チップおよび電極チップの製造方法 |
| KR20180107127A (ko) * | 2016-01-28 | 2018-10-01 | 킴벌리-클라크 월드와이드, 인크. | Rna 바이러스에 대한 유착 조성물 및 표면으로부터 rna 바이러스를 제거하는 방법 |
| EP3418730A4 (en) | 2016-02-16 | 2019-10-30 | Seikagaku Corporation | ELECTROCHEMICAL MEASUREMENT USING A PHENYLENEDIAMINE DERIVATIVE |
| CN105866080B (zh) * | 2016-04-05 | 2019-11-12 | 中国科学院苏州生物医学工程技术研究所 | 重组鲎三因子试剂及其检测内毒素的方法 |
| WO2018074498A1 (ja) | 2016-10-18 | 2018-04-26 | 生化学工業株式会社 | リムルス属由来の組換え蛋白質及びこれをコードするｄｎａ |
| AU2018227210B2 (en) | 2017-03-01 | 2023-11-09 | Seikagaku Corporation | Horseshoe crab factor B variant |
| CN108913707B (zh) * | 2018-07-23 | 2021-06-15 | 广东医科大学 | 一种特异性检测内毒素的试剂及其制备方法 |
| CN112639118A (zh) * | 2018-10-03 | 2021-04-09 | 生化学工业株式会社 | 内毒素测定剂的灵敏度的增强方法 |
| EP4137817A4 (en) | 2020-04-16 | 2024-08-07 | Kikkoman Corporation | HYDROLASE-USED METHOD FOR TRACE SUBSTANCE MEASUREMENT |
| FR3125336B1 (fr) * | 2021-07-19 | 2023-07-14 | Biomerieux Sa | Procédé de quantification d'endotoxines d'un échantillon biologique |
| US20250044296A1 (en) | 2021-08-04 | 2025-02-06 | Seikagaku Corporation | Reagent for measuring b-glucan, method for producing same and use thereof |
| CN114317504B (zh) * | 2021-12-28 | 2023-07-25 | 健帆生物科技集团股份有限公司 | 一种鲎因子c截短蛋白及其制备方法和应用 |
| WO2024254215A1 (en) * | 2023-06-05 | 2024-12-12 | Charles River Laboratories, Inc. | Recombinant amebocyte clotting factors and uses thereof |
| CN118581071B (zh) * | 2024-06-05 | 2025-10-10 | 郑州伊美诺生物技术有限公司 | 一种重组鲎试剂及其制备方法、应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK255887D0 (da) * | 1987-05-20 | 1987-05-20 | Claus Koch | Immunoassay |
| JP3322700B2 (ja) * | 1992-09-14 | 2002-09-09 | 生化学工業株式会社 | 固相系反応用エンドトキシン特異的測定剤 |
| JP3242733B2 (ja) * | 1993-02-26 | 2001-12-25 | 生化学工業株式会社 | エンドトキシン特異的測定剤 |
| JP3429036B2 (ja) * | 1993-09-30 | 2003-07-22 | 生化学工業株式会社 | エンドトキシンの特異的測定剤 |
| US5716834A (en) * | 1994-08-19 | 1998-02-10 | National University Of Singapore | Cloned factor C cDNA of the Singapore horseshoe crab, Carcinoscorpius rotundicauda and purification of factor C proenzyme |
| US6645724B1 (en) * | 1997-09-19 | 2003-11-11 | National University Of Singapore | Assays for endotoxin |
| EP1015609B1 (en) * | 1997-09-19 | 2004-09-01 | National University Of Singapore | A novel generation of cloned horseshoe crab recombinant factor c for detection and removal of endotoxin |
| WO2003002976A2 (en) * | 2001-06-28 | 2003-01-09 | Biowhittaker, Inc. | Methods and reagents for detecting endotoxin |
| JPWO2008004674A1 (ja) * | 2006-07-07 | 2009-12-10 | 生化学工業株式会社 | プロクロッティングエンザイム、並びに、これを用いたエンドトキシン又は（１→３）−β−Ｄ−グルカンの検出方法 |
| JP2011244760A (ja) * | 2010-05-28 | 2011-12-08 | Sumitomo Chemical Co Ltd | 生体組織再生を促進させる薬剤を製造するための加工細胞 |
| CN105866080B (zh) * | 2016-04-05 | 2019-11-12 | 中国科学院苏州生物医学工程技术研究所 | 重组鲎三因子试剂及其检测内毒素的方法 |
-
2012
- 2012-02-28 SG SG10202110031Y patent/SG10202110031YA/en unknown
- 2012-02-28 SG SG10201601351WA patent/SG10201601351WA/en unknown
- 2012-02-28 EP EP12710808.2A patent/EP2681564B1/en not_active Not-in-force
- 2012-02-28 EP EP17190094.7A patent/EP3273244B1/en active Active
- 2012-02-28 SG SG2013055892A patent/SG192578A1/en unknown
- 2012-02-28 ES ES17190094T patent/ES2763089T3/es active Active
- 2012-02-28 CN CN201280010708.4A patent/CN103562724B/zh active Active
- 2012-02-28 ES ES12710808.2T patent/ES2650170T3/es active Active
- 2012-02-28 CN CN201610799888.9A patent/CN106432457A/zh active Pending
- 2012-02-28 WO PCT/JP2012/055728 patent/WO2012118226A1/en not_active Ceased
- 2012-02-28 US US14/001,138 patent/US20140024062A1/en not_active Abandoned
- 2012-02-28 EP EP19160846.2A patent/EP3517962A1/en active Pending
- 2012-02-28 JP JP2013538748A patent/JP2014510898A/ja active Pending
-
2015
- 2015-05-05 US US14/704,230 patent/US20150252405A1/en not_active Abandoned
-
2016
- 2016-11-22 US US15/359,058 patent/US20170138945A1/en not_active Abandoned
-
2018
- 2018-04-09 JP JP2018074569A patent/JP6640267B2/ja active Active
- 2018-05-18 US US15/984,288 patent/US11162949B2/en active Active
-
2019
- 2019-12-25 JP JP2019233842A patent/JP2020100622A/ja active Pending
-
2021
- 2021-10-01 US US17/449,736 patent/US20220018841A1/en active Pending
-
2022
- 2022-05-25 JP JP2022085191A patent/JP7372392B2/ja active Active
-
2023
- 2023-10-19 JP JP2023180059A patent/JP7590530B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN103562724B (zh) | 2016-10-05 |
| JP2018141797A (ja) | 2018-09-13 |
| EP2681564B1 (en) | 2017-10-25 |
| US20140024062A1 (en) | 2014-01-23 |
| SG10201601351WA (en) | 2016-03-30 |
| JP2022119887A (ja) | 2022-08-17 |
| WO2012118226A1 (en) | 2012-09-07 |
| JP2014510898A (ja) | 2014-05-01 |
| CN106432457A (zh) | 2017-02-22 |
| EP3273244B1 (en) | 2019-09-25 |
| EP2681564A1 (en) | 2014-01-08 |
| JP7590530B2 (ja) | 2024-11-26 |
| US20220018841A1 (en) | 2022-01-20 |
| SG192578A1 (en) | 2013-09-30 |
| US20180259527A1 (en) | 2018-09-13 |
| JP7372392B2 (ja) | 2023-10-31 |
| JP2020100622A (ja) | 2020-07-02 |
| ES2763089T3 (es) | 2020-05-27 |
| EP3273244A1 (en) | 2018-01-24 |
| US20170138945A1 (en) | 2017-05-18 |
| EP3517962A1 (en) | 2019-07-31 |
| CN103562724A (zh) | 2014-02-05 |
| SG10202110031YA (en) | 2021-10-28 |
| US11162949B2 (en) | 2021-11-02 |
| US20150252405A1 (en) | 2015-09-10 |
| JP6640267B2 (ja) | 2020-02-05 |
| JP2024010024A (ja) | 2024-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2650170T3 (es) | Agente para la medición de endotoxinas | |
| JP6626174B2 (ja) | 新規組換えファクターｃ、その製造法、およびエンドトキシンの測定法 | |
| ES2674079T3 (es) | Método para la producción recombinante de la proteína del factor C de cangrejo herradura | |
| JP2017060486A (ja) | 組換えプロクロッティングエンザイムを用いたエンドトキシンの検出方法 | |
| ES2978162T3 (es) | Método para producir un agente de detección de endotoxinas que comprende el factor C recombinante de Limulus y su uso | |
| JP7358509B2 (ja) | カブトガニ由来組換えＦａｃｔｏｒＧ及びこれを用いたβ－グルカンの測定方法 | |
| CN107501396B (zh) | 一种用于诊断sfts患者预后情况的蛋白质及其应用 | |
| ES2621326T3 (es) | Proteínas recombinantes derivadas del colágeno con actividad de enlace al factor Willebrand | |
| CN109055411A (zh) | 抑制WSSV增殖的半胱天冬氨酸酶基因Cq-caspase及其蛋白抗病毒活性应用 |